Machine Learning in Drug Discovery and Development Part 1: A Primer

75Citations
Citations of this article
187Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Artificial intelligence, in particular machine learning (ML), has emerged as a key promising pillar to overcome the high failure rate in drug development. Here, we present a primer on the ML algorithms most commonly used in drug discovery and development. We also list possible data sources, describe good practices for ML model development and validation, and share a reproducible example. A companion article will summarize applications of ML in drug discovery, drug development, and postapproval phase.

Cite

CITATION STYLE

APA

Talevi, A., Morales, J. F., Hather, G., Podichetty, J. T., Kim, S., Bloomingdale, P. C., … Conrado, D. J. (2020). Machine Learning in Drug Discovery and Development Part 1: A Primer. CPT: Pharmacometrics and Systems Pharmacology, 9(3), 129–142. https://doi.org/10.1002/psp4.12491

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free